Virtus Pharmaceuticals Private Limited
About Virtus Pharmaceuticals Private Limited
Data last updated:
Virtus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 21 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2014PTC092440. Its GSTIN is 36AAECV7144F1Z9 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shyam Kumar Bommakanti and Jayashree Bommakanti.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Mig – 3L/1 3rd Phase Opp. Anupama Hospital Lane Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.02 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹86,247 (net margin 0.8%) and EBITDA of ₹1.62 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Virtus Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100AP2014PTC092440. The current CIN is U24100TG2014PTC092440, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2014PTC092440 | Current |
| U24100AP2014PTC092440 | Previous |
Contact details
Virtus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMig – 3L/1 3rd Phase Opp. Anupama Hospital Lane Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Virtus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Virtus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Virtus Pharmaceuticals Private Limited, buy the company report.
Financials of Virtus Pharmaceuticals Private Limited
FY 2023 filings availableVirtus Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr (up 6% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 6% growth in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹86,247 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Virtus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Virtus Pharmaceuticals Private Limited
Virtus Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Kumar Bommakanti | Director | 21 Jan 2014 | 12 Years 9 Months | Current |
| Jayashree Bommakanti | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Virtus Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Next Era Pharmaceuticals Private Limited | ₹1.03 Cr (FY 2025) | 10.0% | Indore, Madhya Pradesh, India | |||
| Wiliance Pharmaceuticals Private Limited | ₹1.03 Cr (FY 2025) | -6.0% | Bhopal, Madhya Pradesh, India | |||
| Virtus Pharmaceuticals Private Limitedthis company | ₹1.02 Cr (FY 2023) | ₹86,247 | 0.8% | 6.0% | Hyderabad, Telangana, India | |
| Velliq Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 20.0% | Hyderabad, Telangana, India | |||
| C W C Pharmaceuticals Pvt. Ltd. | ₹1.02 Cr (FY 2025) | 4.0% | Haryana, India | |||
| 4Life Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 22.0% | Jaipur, Rajasthan, India | |||
| Alleviate Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | -8.0% | Panchkula, Haryana, India |
To see the full peer comparison of Virtus Pharmaceuticals Private Limited, buy the company report.
Auditor
Virtus Pharmaceuticals Private Limited is audited by R.M.M. RAJU & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.M.M. RAJU & CO. | FY 2017 | 013362S |
Shareholding
The shareholding of Virtus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Virtus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Virtus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Virtus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Virtus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECV7144F1Z9 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Virtus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Virtus Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Jayashree Bommakanti was appointed as Director on 01 Oct 2021.
Frequently asked questions
Virtus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 21 January 2014 (12+ years old) and is registered under CIN U24100TG2014PTC092440.
Virtus Pharmaceuticals has 2 current directors:
- Shyam Kumar Bommakanti - Director
- Jayashree Bommakanti - Director
The latest financial statements of Virtus Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Virtus Pharmaceuticals is 36AAECV7144F1Z9, registered in Telangana.
The CIN (Corporate Identification Number) of Virtus Pharmaceuticals is U24100TG2014PTC092440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virtus Pharmaceuticals was incorporated on 21 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Virtus Pharmaceuticals by revenue are Next Era Pharmaceuticals Private Limited, Wiliance Pharmaceuticals Private Limited, Velliq Pharmaceuticals Private Limited, C W C Pharmaceuticals Pvt. Ltd, 4Life Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jayashree Bommakanti was appointed as Director on 01 Oct 2021. Sudheer Babu Kochuri ceased to be Director on 01 Oct 2021. Srinivasulu Ekambaram ceased to be Director on 16 Mar 2020. Virtus Pharmaceuticals has 4 board changes on record in total.
The registered office of Virtus Pharmaceuticals is at Mig – 3L1 3rd Phase Opp. Anupama Hospital Lane Kphb Colony Kukatpally, Hyderabad, Telangana, India – 500072.
Virtus Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Virtus Pharmaceuticals is compliant as of 26 September 2026. The company is actively filing with the Registrar of Companies.